Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma
I‐Tsang Chiang, Yu‐Chang Liu, Huashan Liu, Ahmed Ali, Szu‐Yi Chou, Tsung‐I Hsu, Fei‐Ting Hsu
Topics & Concepts
RegorafenibTemozolomideCancer researchCXCR4Signal transductionGene knockdownMedicineApoptosisBiologyChemokineColorectal cancerGliomaInternal medicineCancerCell biologyReceptorBiochemistryGlioma Diagnosis and TreatmentCancer Mechanisms and TherapyChemokine receptors and signaling